NEWSROOM

Blog

Aclarion Added to PRISM Emerging Medical Devices Index

Aclarion Added to PRISM Emerging Medical Devices Index

Sep 6, 2024

Company's industry-first technology addresses chronic low back pain Aclarion secured its first commercial agreement with Michigan's Sheridan Community Hospital PRISM Emerging Medical Devices Index features companies at forefront of innovation and market disruption in medtech NEW YORK, September 06, 2024 – PRISM MarketView, a leading provider of market insights and company news, is excited to announce that Aclarion, Inc. (NASDAQ: ACON) has been added to the PRISM Emerging Medical Devices Index,...

IBC GUYANA 2024: THE GATEWAY TO OPPORTUNITIES

IBC GUYANA 2024: THE GATEWAY TO OPPORTUNITIES

Sep 5, 2024

IBC GUYANA: THE GATEWAY TO OPPORTUNITIES 15-17 October, Georgetown, Guyana New York, September 5, 2024 - PRISM MediaWire - The International Business Conference, 15-17 October 2024, Georgetown, Guyana will be hosted under the theme of ‘Guyana: The Gateway to Opportunities’. IBC 2024 is co-hosted by Suriname-Guyana Chamber of Commerce (SGCC) and Guyana Manufacturing and Services Association (GMSA) and supported by the Guyana Office for Investment and Suriname...

AmpliTech Group’s AGTGSS Division To Participate At Mobile World Congress Shows in Las Vegas And Barcelona To Market Its Comprehensive Private 5G End-to-End Solution for Businesses and Homes

Sep 4, 2024

This includes External and Internal CPE and Fixed 5G Wireless Access (FWA) equipment Hauppauge, NY, September 4, 2024 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, announces the company’s...

AB INTL GROUP Announces Launch of a Film Entity as Subsidiary in China

AB INTL GROUP Announces Launch of a Film Entity as Subsidiary in China

Sep 4, 2024

NEW YORK, September 4, 2024 -- AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces the launch of a wholly owned subsidiary in China, which is aiming to tap into one of the world's largest and most dynamic film markets. 1.Market Access and Revenue Potential: China's film industry has been rapidly growing, ranking as the second-largest box office market globally. By establishing a subsidiary there, ABQQ gains direct access to...

HOLIDAY ISLAND HOLDINGS, INC. HAS STARTED OIL PRODUCTION AT ITS WINDY POINT WELL IN CENTRAL TEXAS

HOLIDAY ISLAND HOLDINGS, INC. HAS STARTED OIL PRODUCTION AT ITS WINDY POINT WELL IN CENTRAL TEXAS

Sep 4, 2024

Plant City, Florida, September 4, 2024 - PRISM MediaWire - Holiday Island Holdings, Inc. (OTC: HIHI) (soon to be EP3Oil, Inc.) announced today that it has started pumping oil into production tanks at its Windy Point well located in Central Texas. Windy Point is one of many wells to be developed on the 300-acre lease controlled by HIHI. Based on geological surveys, the company is sitting on a large proven oil reserve. Glenn Klinker, CEO, is quoted: “We are very pleased with the progress...

Halberd Corp. Issues Letter to Shareholders – Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction

Halberd Corp. Issues Letter to Shareholders – Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction

Sep 4, 2024

Early Pilot Study Data from Veteran Volunteers is Compelling Jackson Center, PA September 4, 2024 - PRISM MediaWire - Halberd Corporation (OTC: HALB) To our shareholders: As promised, this is the second of three Press Releases on our recent progress. If you have not had a chance to review that last one, on the good news on our Tri-aX™ Nasal Spray for TBI, please do. This one follows the same process. This Press Release is focused on LDN+, as related to Post Traumatic Stress Disorder (PTSD) and...

Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy

Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy

Sep 4, 2024

Company will use novel, patented Klotho Gene (s-KL) in studies New York, NY, September 4, 2024 - PRISM MediaWire - ANEW MEDICAL, INC. (NASDAQ: WENA), a U.S. biotechnology company, announced that it has two distinct goals for its pioneering cell and gene therapy development. One is to enhance the potential of people achieving a healthy long life, and the other is the development of effective treatments for age-related disorders and neurodegenerative diseases such as ALS, Alzheimer’s and...

SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America

SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America

Sep 3, 2024

SS Innovations receives Regulatory Approval for Clinical Use in Ecuador SS Innovations Partners with Medical Device Firm Ingemedica S.A. for Distribution in Ecuador The first SSi Mantra Surgical Robotic System to be installed at Interhospital, Guayaquil City, Ecuador Fort Lauderdale, FL., September 3, 2024 - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery...

SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock

SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock

Aug 30, 2024

Fort Lauderdale, FL., August 30, 2024 - PRISM MediaWire - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today issued an update to its shareholders and the investment community on the status of its audit process and the trading market for its common stock. As previously reported in its Securities and Exchange...

AmpliTech Group’s Bookings Surpass $1M In August 2024

AmpliTech Group’s Bookings Surpass $1M In August 2024

Aug 30, 2024

In Addition To Above Bookings, Spectrum Semiconductor Materials Division Completes $700K Single Sale Transaction During The Week of August 26th 2024 Hauppauge, NY, August 30, 2024 – PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and...

A New Era of Growth and Innovation at JP3E – A Message from the New CEO

A New Era of Growth and Innovation at JP3E – A Message from the New CEO

Aug 30, 2024

NEW YORK, Aug. 30, 2024 - PRISM MediaWire -JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc. Dear JP3E Shareholders, I am both honored and excited to introduce myself as the new CEO of JP 3E Holdings. As we embark on this pivotal moment in our company's history, I am eager to share the vision and strategic direction to guide us into a future brimming with potential and opportunity. At JP3E, we are at the intersection of cutting-edge technologies and expanding market opportunities. Our...

Shorepower Technologies Wins Phase 1 Contract with US Department of Energy

Shorepower Technologies Wins Phase 1 Contract with US Department of Energy

Aug 30, 2024

Eligible to Apply for Phases 2 and 3, valued at $650k PORTLAND, August 30, 2024 - In June 2024, the U.S. Department of Energy (DOE) announced the 20 teams from 13 states who won Phase 1: Identify! for the Hero Re-X Before Recycling Prize challenge. Shorepower Technologies Inc. (OTC: SPEV) is pleased to announce they are among this winning cohort and now qualify to participate in Phases 2 and 3, which could yield additional awards of up to $650,000 - to demonstrate and develop an innovative...

Premier Graphene’s Proprietary Graphene-Modified Asphalt Demonstrates Substantial Stability and Performance Improvements Compared to Conventional Asphalt in Laboratory Tests

Premier Graphene’s Proprietary Graphene-Modified Asphalt Demonstrates Substantial Stability and Performance Improvements Compared to Conventional Asphalt in Laboratory Tests

Aug 29, 2024

Imperial Valley, California, August 29, 2024 – Premier Graphene Inc. (OTC: BIEI), formerly Premier Biomedical Inc., announced today a groundbreaking technical report with significant implications for the road and highway construction industries. Building on our successful integration of our high-grade, efficacious graphene in cement, the testing conducted by Baja California Test S.A. de R.L. de C.V., highlights that the integration of graphene into asphalt mixtures, demonstrates again...

BioStem Technologies Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET

BioStem Technologies Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET

Aug 29, 2024

Advanced wound care MedTech company recently reported a record second-quarter with $116.4M in revenue for H1, 2024 POMPANO BEACH, Fla., Aug. 29, 2024 -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, will present at the H.C. Wainwright 26th Annual Global Investment Conference held on September 9th through 11th in New York City at the Lotte Palace Hotel....

BranchOut Food Delivers Shareholder Update: 2024 Revenue Surges 640% in First Half, Poised for Continued Growth and Debt Elimination by Q4 2025

BranchOut Food Delivers Shareholder Update: 2024 Revenue Surges 640% in First Half, Poised for Continued Growth and Debt Elimination by Q4 2025

Aug 28, 2024

BranchOut Food estimated to finish year at $8 million in Net Revenue Net Revenue for 1st half 2024 up over 640% from revenue in 1st half 2023 The Company estimates $5 million in Revenue for 2nd half of 2024, double that of the same period last year, to finish 2024 near $8 million Opening new production facility in Peru with about $40 mm in capacity with first production anticipated in October Completed combined financing of $5.4 million in June and July 2024 to finance completion of new...

BLAQclouds, Inc. Announces Initial Launch of BLAQ Token on BLAQlp.io

BLAQclouds, Inc. Announces Initial Launch of BLAQ Token on BLAQlp.io

Aug 27, 2024

Las Vegas, NV, August 27, 2024 — BLAQclouds, Inc. (OTC: BCDS) is pleased to announce that this week, the company will launch its first liquidity pool partnership on BLAQlp.io with the debut of the BLAQ token on both the Ethereum and ZEUS blockchains. The exact date and time for the launch will be announced with 24 hours prior notice, based on market conditions and other factors. As previously announced, the core smart contract powering BLAQlp.io allows funders to directly contribute to...

Lipella Pharmaceuticals to Participate at H.C. Wainwright’s 26th Annual Global Investment Conference in New York

Lipella Pharmaceuticals to Participate at H.C. Wainwright’s 26th Annual Global Investment Conference in New York

Aug 27, 2024

Company has two lead drug candidates for rare disease indications in IND approved phase 2 clinical trials using the 505(b)(2) pathway Pittsburgh, PA, August 27, 2024 – Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella”) will participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York City at the Lotte New York Palace Hotel on September 9 through 11, 2024. Admission to H.C. Wainwright’s conference is for qualified investors, and Lipella will be giving a virtual...

AmpliTech Group’s Bookings Surpass $1M In August 2024

AmpliTech Group’s AGMDC Division Moves to Allen Tech Hub in Watters Creek District in Allen, Texas

Aug 26, 2024

Hauppauge, NY, August 26, 2024 – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced its AmpliTech Group Microwave Design Center move into the prestigious cutting-edge Allen Tech Hub in the heart of...

AB INTL GROUP Announces Launch of a Film Entity as Subsidiary in China

AB INTL GROUP Announces Repurchase of Common Stock for Cancelation

Aug 26, 2024

NEW YORK, Aug. 26, 2024 - AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, today announced a repurchase of 50,296,980 shares of common stock for cancelation. Its positive cash flow continues to come from net profitability to enable the repurchase of more shares in the near future. On August 21, 2024, AB International Group Corp. (the “Company”) entered into Repurchase Agreements with seven shareholders, all non-affiliates of the...

Halberd Corp. Issues Letter to Shareholders – Patented LDN+ Evolves into WatchDawg™ for Veteran Suicide Reduction

Halberd Corp. Issues Letter to Shareholders

Aug 26, 2024

JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to its shareholders: Halberd Corp. - Taking a Moment to Recenter Our Technical Progress Introducing Tri-ax™ TBI Nasal Spray Treatment- the DoD selected our MSU-led pre-proposal, inviting us to submit a full application/proposal This is the first of a series of three significant Press Releases we plan to issue shortly. Many of our investors have been voicing...

Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy

ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility

Aug 26, 2024

Successful Conversion Eliminates Over $4 Million in Long-Term Debt New York, NY, August 26, 2024 - ANEW MEDICAL, INC. (NASDAQ: WENA), a leading U.S. biotechnology company pioneering cell and gene-based treatments for aging and age-related diseases, announces the successful conversion of its convertible promissory notes by investors. This strategic move significantly strengthens ANEW’s balance sheet by eliminating over $4 million in long-term debt. The elimination of over $4 million in...

Biofuels Brazil Forum 2024

Biofuels Brazil Forum 2024

Aug 23, 2024

Biofuels Brazil Forum 2024 Date: 27-28 November 2024, Sao Paulo, BrazilOrganizer: Vostock CapitalWebsite "Biofuels Brazil International Investment Forum" is the premier platform for biofuel producers, regulatory bodies, government officials, technology pioneers, equipment suppliers, EPC, engineering companies, and investors from Brazil, Latin America, and Europe. It fosters strategic partnerships and innovation in the biofuels sector, advancing Brazil's leadership in sustainable development...

Foro Biocombustibles Brasil 2024

Foro Biocombustibles Brasil 2024

Aug 23, 2024

Foro Biocombustibles Brasil 2024 Fecha: 27-28 de noviembre de 2024, São Paulo, BrasilOrganizador: Vostock CapitalWebsite El "Foro Internacional de Inversiones en Biocombustibles de Brasil" es la plataforma principal para productores de biocombustibles, organismos reguladores, funcionarios gubernamentales, pioneros tecnológicos, proveedores de equipos, empresas de EPC y de ingeniería, e inversores de Brasil, América Latina y Europa. Fomenta alianzas estratégicas e innovación en el sector de los...

Fórum de Biocombustíveis Brasil 2024

Fórum de Biocombustíveis Brasil 2024

Aug 23, 2024

Fórum de Biocombustíveis Brasil 2024 Data: 27-28 de novembro de 2024, São Paulo, Brasil Organizador: Vostock Capital Website O "Fórum Internacional de Investimentos em Biocombustíveis Brasil" é a principal plataforma para produtores de biocombustíveis, órgãos reguladores, autoridades governamentais, pioneiros em tecnologia, fornecedores de equipamentos, empresas de EPC e engenharia, e investidores do Brasil, América Latina e de outras regiões. O evento promove parcerias...

“Mining Chile and Latin America 2024” in Santiago de Chile

“Mining Chile and Latin America 2024” in Santiago de Chile

Aug 23, 2024

“Mining Chile and Latin America 2024” in Santiago de Chile Meet industry leaders and learn the best practices for the mining sector. Date: October 1st and 2nd 2024 Place: Santiago de Chile Organizer: Vostock Capital Website 5th International Congress and Exhibition Mining Chile and Latin America 2024 brings together, during two days, + 200 decision-makers from national and international companies, + 40 Mining Projects in Chile technology and service providers, and international...

Congreso Internacional y Exhibición “Minería Chile y América Latina 2024″

Congreso Internacional y Exhibición “Minería Chile y América Latina 2024″

Aug 23, 2024

Congreso Internacional y Exhibición “Minería Chile y América Latina 2024" Fecha: 1 y 2 de octubre 2024 Lugar: Santiago de Chile Organizador: Vostock Capital Sitio Web El 5º Congreso y Exhibición Internacional Minería Chile y América Latina 2024 reúne a más de 200 ejecutivos con poder de decisión de empresas nacionales e internacionales, más de 40 proyectos de Mineria en America latina, proveedores de tecnología y servicios, inversionistas internacionales y locales para discutir las principales...

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Aug 22, 2024

Affecting about 6 million Americans, OLP is a chronic inflammatory disease affecting the mucous membranes of the mouth No FDA-approved therapy currently exists for OLP Patient registry and OLP study information is now available Pittsburgh, PA, August 22, 2024 – Lipella Pharmaceuticals, Inc. (NASDAQ: LIPO) has launched an Oral Lichen Planus (OLP) Patient Registry. This online platform is designed to enhance research and drive the development of new treatments for OLP, a chronic inflammatory...

BioStem Technologies Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET

BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers

Aug 21, 2024

Study supports BioStem’s strategic growth initiatives and accelerates product adoption by providing data to healthcare professionals and payers on the benefits of Vendaje POMPANO BEACH, FL, August 21, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the Institutional Review Board (IRB) has approved a clinical study to evaluate Vendaje® for...

Healthy Longevity is One of Key Development Goals of ANEW’s Novel Gene Therapy

ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)

Aug 21, 2024

New York, NY. August 21, 2024 - ANEW MEDICAL, INC. (“ANEW” or the “Company”) (NASDAQ: WENA), announced the signing of an exclusive worldwide license agreement with Transfertech Sherbrooke(“TTS”)regarding Nanoject, a needle-free, freeze-dried nanopowder autoinjector for medicines and vaccines. Needle phobia and injection or blood-drawing anxiety are prevalent among adults and children, creating barriers to adhering to doctor visits and medication protocols. Alternatives to needle/syringes have...

Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research

Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference

Aug 21, 2024

LP-20 contrast agent designed to diagnose interstitial cystitis and detect bladder cancer Novel MRI contrast agent, which received support from National Institute of Diabetes and Digestive and Kidney Diseases 5th International Consultation on Interstitial Cystitis Japan runs Aug. 21-23 in Kyoto Pittsburgh, PA, August 21, 2024 – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotech company, will highlight clinical data on LP-20, a novel MRI contrast agent designed for diagnosing...